News News
Media Bias Chart - New
Pricing & Services
Bias Meter
Tools
Clinical trial Follow
Lawmakers express concerns over US pharma companies' involvement in clinical trials alongside China
Xinjiang
Lawmakers express concerns over US pharma companies' involvement in clinical trials alongside China
Asian News International (ANI)
Aug 25, 2024

Center

...
View Bias Rating
World News | Lawmakers Express Concerns over US Pharma Companies' Involvement in Clinical Trials Alongside China | LatestLY
Clinical trial
World News | Lawmakers Express Concerns over US Pharma Companies' Involvement in Clinical Trials Alongside China | LatestLY
LatestLY
Aug 25, 2024

Center

...
View Bias Rating
Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma - Replimune Group (NASDAQ:REPL)
Standard of care
Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma - Replimune Group (NASDAQ:REPL)
Benzinga
Aug 13, 2024

Center

...
View Bias Rating
Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Clinical trial
Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
wallstreet:online
Aug 12, 2024

Center

...
View Bias Rating
The consequences of ending abortion protection, th | Newswise
Chicago
The consequences of ending abortion protection, th | Newswise
d.newswise.com
Jul 28, 2024

Center

...
View Bias Rating
Technology/innovation point to economic resilience, opportunity
Chief operating officer
Technology/innovation point to economic resilience, opportunity
Yahoo! Finance
Jul 14, 2024

Somewhat Liberal

...
View Bias Rating
Technology/innovation signals economic resilience and opportunity - ExBulletin
Chief operating officer
Technology/innovation signals economic resilience and opportunity - ExBulletin
ExBulletin
Jul 14, 2024

Somewhat Liberal

...
View Bias Rating
default thumbnail
Asia
New Report Highlights Global Trends and Advances in Chronic Lymphocytic Leukemia Research and Treatment
npinvestor.dk
Jul 11, 2024

Medium Liberal

...
View Bias Rating
YPrime Research Reveals User-Centric eCOA Technologies as Key to Overcoming Challenges ...
Clinical trial
YPrime Research Reveals User-Centric eCOA Technologies as Key to Overcoming Challenges ...
Eagle-Tribune
Jun 25, 2024

Somewhat Liberal

...
View Bias Rating
BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep ™S™ for Depression By Investing.com
Major depressive disorder
BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep ™S™ for Depression By Investing.com
Investing.com UK
Jun 10, 2024

Center

...
View Bias Rating
BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression - BrainsWay (NASDAQ:BWAY)
Major depressive disorder
BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression - BrainsWay (NASDAQ:BWAY)
Benzinga
Jun 10, 2024

Center

...
View Bias Rating
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
Amgen
Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It?
Yahoo! Finance
May 26, 2024

Center

...
View Bias Rating
Star USC scientist faces scrutiny -- retracted papers and a paused drug trial
National Institutes of Health
Star USC scientist faces scrutiny -- retracted papers and a paused drug trial
Twin Cities Pioneer Press
May 25, 2024

Somewhat Liberal

...
View Bias Rating
Mifepristone is safer than pregnancy. It's safer than Viagra. Our patients need it. (Opinion)
Mifepristone
Mifepristone is safer than pregnancy. It's safer than Viagra. Our patients need it. (Opinion)
Houston Chronicle
Apr 19, 2023

Center

...
View Bias Rating
Biotech AI startup Unlearn adds $15 mln and OpenAI CTO to board
Startup company
Biotech AI startup Unlearn adds $15 mln and OpenAI CTO to board
Reuters
Mar 21, 2023

Center

...
View Bias Rating
View More